Press release
Lung Cancer Screening Market Size, Share, Trends, Outlook, Growth, Analysis, Report and Forecast 2024-2032
The global lung cancer screening market size was valued at USD 2.5 billion in 2023, driven by increasing prevalence of lung cancer. The market size is anticipated to grow at a CAGR of 8.2% during the forecast period of 2024-2032 to achieve a value of USD 5.1 billion by 2032.Lung Cancer Screening: Introduction
Lung cancer screening is a medical procedure used to detect lung cancer in its early stages, particularly among high-risk individuals, such as long-term smokers. The most common method is low-dose computed tomography (LDCT), a type of X-ray that provides detailed images of the lungs, enabling the detection of small nodules or abnormalities that may indicate early-stage lung cancer. Early detection through screening is crucial as it significantly improves treatment success rates and overall patient survival.
Get a Free Sample Report with a Table of Contents - https://www.expertmarketresearch.com/reports/lung-cancer-screening-market/requestsample
Key Trends in the Global Lung Cancer Screening Market
Increasing focus on personalized treatment plans based on genetic profiling of tumors, allowing for more targeted and effective therapies. Breakthroughs in immunotherapy are providing new hope, with treatments that help the immune system recognize and fight cancer cells more effectively.
Enhanced emphasis on early detection through advanced screening technologies like low-dose CT scans, aiming to diagnose lung cancer at more treatable stages. Growing trend towards using a combination of treatment methods, including surgery, radiation, chemotherapy, and targeted therapies, to improve patient outcomes.
Integration of digital tools and AI in diagnostics, treatment planning, and patient monitoring, aiming to optimize treatment paths and improve prognostic evaluations. Increased availability of support services focusing on the mental and emotional well-being of patients and their families, recognizing the importance of holistic care in cancer treatment.
Evolving regulatory policies and reimbursement models to support the adoption of innovative treatments and ensure patients have access to the latest and most effective therapies.
Read Full Report with Table of Contents - https://www.expertmarketresearch.com/reports/lung-cancer-screening-market
Lung Cancer Screening Market Segmentation
Market Breakup by Type
Low dose computed tomography (LDCT)
X-ray
Market Breakup by Age Group
50 and older
Below 50
Market Breakup by End User
Hospitals
Diagnostic Centers
Others
Market Breakup by Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Lung Cancer Screening Market Overview
In North America, the lung cancer market is highly advanced with a strong emphasis on early detection and cutting-edge treatment options. There is a significant focus on lung cancer screening programs, particularly using low dose computed tomography (LDCT), to catch the disease at a more treatable stage. The region also sees a high adoption rate of targeted therapies and immunotherapies, reflecting its robust pharmaceutical and biotechnology sectors.
Europe's lung cancer market is characterized by comprehensive healthcare systems and substantial government support for healthcare research. The region has strict tobacco control policies contributing to prevention efforts. There's a strong focus on integrating advanced diagnostics, including molecular biomarker testing, to guide targeted treatment approaches. Additionally, Europe is a hub for clinical trials, aiming to develop and approve innovative therapies.
The lung cancer market in the Asia Pacific region is rapidly growing, driven by increasing healthcare expenditure and a rising incidence of lung cancer. The market is diverse, with countries at various stages of healthcare infrastructure development. There's a growing emphasis on improving healthcare facilities, increasing public awareness about cancer prevention and early detection, and adopting modern treatment modalities. Countries like Japan and South Korea are leading in technological adoption, while others are progressively enhancing their healthcare systems to provide better cancer care.
Lung Cancer Screening Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
Canon Medical Systems
Eon Health
Fujifilm Holdings Corporation
Koninklijke Philips N.V.
Medtronic Plc
Microsoft Corporation (Nuance Communications, Inc)
Penrad Technologies Inc.
Miltenyi Biotech
Volpara Solutions Limited.
General Electric
Read More Reports
Ophthalmic Devices Market - https://www.expertmarketresearch.com/reports/ophthalmic-devices-market
Anti-Infectives Market - https://www.expertmarketresearch.com/reports/anti-infectives-market
Portable Ultrasound Market - https://www.expertmarketresearch.com/reports/portable-ultrasound-market
Peptide Therapeutics Market - https://www.expertmarketresearch.com/reports/peptide-therapeutics-market
Media Contact:
Company Name: Claight Corporation
Contact Person: Hester Laurier, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Cancer Screening Market Size, Share, Trends, Outlook, Growth, Analysis, Report and Forecast 2024-2032 here
News-ID: 3458072 • Views: …
More Releases from Expert Market Research
AI in Mental Health Market to Reach USD 8.38B by 2035
How Is Artificial Intelligence Transforming Mental Healthcare?
The Artificial Intelligence in Mental Health Market is rapidly emerging as a transformative force in global healthcare, addressing long-standing challenges such as access, affordability, stigma, and workforce shortages. With more than 970 million people worldwide affected by mental health conditions, the need for scalable, personalized, and data-driven mental health solutions has never been more urgent.
The global artificial intelligence in mental health market was valued…
Brazil Clinical Microbiology Market USD 390.12M | 5.8% CAGR
Why is the Brazil Clinical Microbiology Market gaining strategic importance within Latin America's healthcare ecosystem?
Brazil has one of the largest and most complex healthcare systems in the region, with a growing focus on early disease detection, antimicrobial resistance monitoring, and laboratory automation. Clinical microbiology plays a critical role in identifying infectious diseases, guiding targeted therapies, and supporting public health surveillance.
The Brazil clinical microbiology market was valued at USD 390.12 Million…
Battery Recycling Market Size, Trends and Forecast 2026-2035
The battery recycling market is gaining steady traction as industries and governments focus more on resource efficiency, environmental compliance, and supply chain security for critical metals. With the rising use of lithium-ion, lead-acid, and nickel-based batteries across electric vehicles, consumer electronics, industrial equipment, and energy storage systems, recycling has moved from being a regulatory requirement to a strategic necessity. Battery recycling helps recover valuable materials like lithium, cobalt, nickel, and…
Biometrics Technology Market Size, Trends & Forecast 2026-2035
The biometrics technology market is witnessing robust growth and is expected to continue expanding at a significant pace. Valued at approximately USD 27.78 billion in 2025, the market is projected to grow at a compound annual growth rate (CAGR) of 10.20% between 2026 and 2035. By 2035, the market is expected to reach USD 73.38 billion. This growth is driven by the increasing need for advanced security solutions, innovations in…
More Releases for Lung
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Lung Cancer Drugs Industry Market Size Be by 2025?
The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate…
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Lending And Payments Market?
The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787
This latest report researches the industry structure,…
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor…
